Susquehanna Maintains Positive on Teradyne, Raises Price Target to $550
Susquehanna analyst Mehdi Hosseini maintains Teradyne (NASDAQ: TER ) with a Positive and raises the price target from $415 to $550.
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.